Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies
Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies

| Organisatie | |
| Gepubliceerd in | European Association for Cancer Research 2025 Lisbon, Portugal, PRT |
| Datum | 2025-06-13 |
| Type | |
| Taal | Engels |






























